Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-26-002502
Filing Date
2026-04-16
Accepted
2026-04-16 10:21:36
Documents
2
Period of Report
2026-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_041626.htm 6-K 4419
2 PRESS RELEASE exh_991.htm EX-99.1 10928
  Complete submission text file 0001171843-26-002502.txt   16389
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 26866087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)